ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine

J E Fletcher1, P J Adnet, H Reyford

  • 1Trinity Communications, Conshohocken, Pennsylvania 19428-2977, USA. jfletcher@trinitycom.com

Anesthesiology
|May 13, 1999
PubMed
Abstract

Insights

Altering sodium ion (Na+) channel function with ATX II toxin increased normal muscle sensitivity to malignant hyperthermia (MH) triggering agents. This suggests abnormal Na+ channel function may contribute to MH susceptibility, particularly in males.

Area of Science:

  • Physiology
  • Pharmacology
  • Genetics

Background:

  • Altered sodium ion (Na+) channel function is observed in skeletal muscle of individuals susceptible to malignant hyperthermia (MH).
  • ATX II toxin induces delayed Na+ channel inactivation, mimicking changes seen in MH muscle cultures.
  • Investigating ATX II's effect on normal muscle assesses if Na+ channel dysfunction increases sensitivity to MH-associated agents.

Purpose of the Study:

  • To determine if modifying normal skeletal muscle Na+ channel function with ATX II enhances sensitivity to halothane, caffeine, and ryanodine.
  • To compare the response of ATX II-treated normal muscle to that of MH-susceptible muscle.

Main Methods:

  • Fiber bundles from human vastus lateralis (MH- and MH+ susceptible) and rat diaphragm muscle were used.
  • Muscle preparations were exposed to ATX II followed by halothane, caffeine, or ryanodine in a tissue bath.
  • Contracture force was measured using a force transducer.

Main Results:

  • ATX II increased halothane-induced contractures in most MH- individuals, mimicking MH+ responses.
  • Significant halothane sensitivity was observed in ATX II-treated normal muscle, particularly in male participants.
  • In rat muscle, ATX II potentiated caffeine contractures and accelerated ryanodine-induced contractures.

Conclusions:

  • ATX II enhances normal skeletal muscle sensitivity to MH-associated agents, suggesting a role for Na+ channel dysfunction.
  • Abnormal Na+ channel function, even if secondary, may contribute to positive results in MH diagnostic tests.
  • The findings highlight the potential impact of Na+ channel abnormalities on MH susceptibility and diagnosis.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...